SAbR (stereotactic ablative radiotherapy)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SAbR (stereotactic ablative radiotherapy), covering 2019-05-07 to 2024-07-17. Get the full timeline:
Most recent: Clinical Trial Update: SAbR For Oligo-Progressive Renal Cell Cancer. [Phase 2]